Literature DB >> 14607241

EP2 and EP4 prostanoid receptor signaling.

John W Regan1.   

Abstract

The EP(2) and EP(4) prostanoid receptors are two of the four subtypes of receptors for prostaglandin E(2) (PGE(2)). They are in the family of G-protein coupled receptors and both receptors were initially characterized as coupling to Gs and increasing intracellular cAMP formation. Recently, however, we have shown that both receptors can stimulate T-cell factor (Tcf) mediated transcriptional activity. The EP(2) receptor does this primarily through cAMP-dependent protein kinase (PKA), whereas the EP(4) utilizes phosphatidylinositol 3-kinase (PI3K) as well as PKA. In addition, we have shown that the EP(4) receptor, but not the EP(2), can activate the extracellular signal-regulated kinases (ERKs) 1 and 2 by way of PI3K leading to the induction of early growth response factor-1 (EGR-1), a transcription factor traditionally associated with wound healing. This induction of EGR-1 expression has significant implications concerning the potential role of PGE(2) in cancer and inflammatory disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14607241     DOI: 10.1016/j.lfs.2003.09.031

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  156 in total

1.  Impaired pulmonary immunity post-bone marrow transplant.

Authors:  Stephanie M Coomes; Leah L N Hubbard; Bethany B Moore
Journal:  Immunol Res       Date:  2011-05       Impact factor: 2.829

Review 2.  How it's made: organisational effects of hormones on the developing brain.

Authors:  M M McCarthy
Journal:  J Neuroendocrinol       Date:  2010-07       Impact factor: 3.627

3.  PGE(2) is a UVR-inducible autocrine factor for human melanocytes that stimulates tyrosinase activation.

Authors:  Renny J Starner; Lindy McClelland; Zalfa Abdel-Malek; Alex Fricke; Glynis Scott
Journal:  Exp Dermatol       Date:  2010-05-25       Impact factor: 3.960

Review 4.  Prostaglandin E2 EP receptors as therapeutic targets in breast cancer.

Authors:  Jocelyn Reader; Dawn Holt; Amy Fulton
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

Review 5.  Cyclooxygenases and lipoxygenases in cancer.

Authors:  Claus Schneider; Ambra Pozzi
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

6.  EP1 prostanoid receptor coupling to G i/o up-regulates the expression of hypoxia-inducible factor-1 alpha through activation of a phosphoinositide-3 kinase signaling pathway.

Authors:  Ruyue Ji; Chih-Ling Chou; Wei Xu; Xiao-Bo Chen; David F Woodward; John W Regan
Journal:  Mol Pharmacol       Date:  2010-03-24       Impact factor: 4.436

7.  Prostaglandin E2 reduces radiation-induced epithelial apoptosis through a mechanism involving AKT activation and bax translocation.

Authors:  Teresa G Tessner; Filipe Muhale; Terrence E Riehl; Shrikant Anant; William F Stenson
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

Review 8.  Surprising origins of sex differences in the brain.

Authors:  Margaret M McCarthy; Lindsay A Pickett; Jonathan W VanRyzin; Katherine E Kight
Journal:  Horm Behav       Date:  2015-04-25       Impact factor: 3.587

9.  Strong activation of cyclooxygenase I and II catalytic activity by dietary bioflavonoids.

Authors:  Hyoung-Woo Bai; Bao Ting Zhu
Journal:  J Lipid Res       Date:  2008-07-26       Impact factor: 5.922

10.  Genetic variation in prostaglandin E2 synthesis and signaling, prostaglandin dehydrogenase, and the risk of colorectal adenoma.

Authors:  Elizabeth M Poole; Li Hsu; Liren Xiao; Richard J Kulmacz; Christopher S Carlson; Peter S Rabinovitch; Karen W Makar; John D Potter; Cornelia M Ulrich
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01-19       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.